Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report.

Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report. Cold Spring Harb Mol Case Stud. 2020 12; 6(6).

View in: PubMed

subject areas

Aged
B7-H1 Antigen
Brain Neoplasms
Carcinoma, Non-Small-Cell Lung
Class I Phosphatidylinositol 3-Kinases
Exons
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms
Male
Piperidines
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Pyridazines
Pyrimidines

authors with profiles

Ravi Salgia